Berkeley and Broad fight for CRISPR rights before USPTO
The USPTO has heard what will likely be the last important patent interference proceeding to come before a panel of its judges. The proceedings are going out with a bang with a hearing over the celebrated CRISPR gene editing technology
The interference hearing was held on December 6 to determine whether the Doudna Lab at the University of California, Berkeley or the Broad Institute’s Zhang Lab is the rightful owner of patents related to the technology.
CRISPR has been...
Please log in
to read the rest of this article. New to Managing Intellectual Property?
Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.
Please make sure you log in to read the rest of the article.
Join us nowGain FREE access to up to five free articles when you register now.